Fierce Pharma, in conjunction with Evaluate consensus sales estimates, has put together a list of what expects to be the most anticipated new drug launches in 2021.
The top candidate is Biogen and Eisai’s Alzheimer’s aducanumab. The FDA has recently delayed the decision until June due to the COVID-19 market. Currently
Number two on the list is a COVID-19 candidate by Novavax. Current data is showing 89% effectiveness against the novel coronavirus.
Click here to see the rest of the top 10.